Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Critically-Acclaimed Independent Feature Film THE LAST WHISTLE Shines a Light on Sudden Cardiac Arrest

-- Debuting June 28, 2019, Football Drama Follows a High School Coach at the Center of Scandal When a Player Collapses from Sudden Cardiac Arrest --Having recently won a series of film festival awards, the independent feature film The Last Whistle  will debut on June 28th at theaters in Los Angeles, New York, and in multiple other markets across the U.S. The film will also have a same-day release on iTunes, Amazon, Google Play, and Vudu. The critically-acclaimed football drama follows a high school coach (Brad Leland, best known as “Buddy Garrity” in

SStar Gold Resources first purchase of a mining licence in Russia

SStar Gold Resources AB (publ) board of directors informs about a successful participation in an auction and gives an update regarding the review of the ongoing business initiated by the new Board that took office on January 12, 2019.The office for the Moscow based Russian subsidiary, SStar Trade Gold LLC (“SSTG”), was opened at the end of 2018.  From its’ representative office in Chita (capital of Zabaykal region) SSTG has successfully concluded the purchase of a mining licence during a government auction in May 2019. This allows us to have mining rights over alluvial gold at a Kadarinsky

Notice of extraordinary general meeting in ChromoGenics AB (publ)

The shareholders in ChromoGenics AB (publ) corp. reg. no. 556630-1809 (the “Company”) are hereby convened to an extraordinary general meeting on Tuesday 18 June 2019, at 3 p.m. at Advokatfirman Lindahl’s office on Vaksalagatan 10 in Uppsala, in accordance with Appendix 1. The timetable for the new issue of shares according to item 6 of the notice of the extraordinary general meeting has been finally established in accordance with the below, which entails a few minor adjustments compared to the timetable that was previously made public.18 June Extraordinary general meeting for

Edgeware announces expected revenue range for the second quarter 2019

Edgeware (¨the Company¨) today announces an expected revenue range for the second quarter 2019. Revenues are expected to be in the range of SEK 28-34 million. While Edgeware does not provide forecasts, it chooses to disclose this information since it considers that this level of revenue differs significantly from the general expectations currently in the market.The reason for the decreasing revenue level in the second quarter is that Edgeware currently experiences a weakening of the Company´s Content Delivery Network (CDN) product business with Telecommunication Operators in Western Europe.

iioote at the LoRa Alliance 11th All Member Meeting in Berlin June 11-13 , 2019

Join the LoRa Alliance 11th All Members Meeting & LoRaWAN® Live events in Berlin, Germany  The first two days are for Sponsor/Contributor/Institutional Members only. Thursday, June 13: 9:00am - 7:00pm LoRaWAN® Live and Market Place - Open to all Members and external guests. This special program, sponsored by Minol Zenner Connect GmbH, is a must-attend event for all.  It will be open for new and prospective members / end-users of LoRaWAN® and will focus on advancing business development opportunities across our ecosystem. This will be a day of educational programs and

Stillfront Group acquires KIXEYE, Inc. and secures new debt financing

NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SOUTH AFRICA OR NEW ZEALAND OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL Pressrelease Stockholm 2019-06-03Stillfront Group AB (publ) ("Stillfront") has today entered into an agreement with the owners of KIXEYE, Inc. a leading developer and publisher of online strategy games headquartered in Canada, to acquire 100 percent of the shares in KIXEYE (“KIXEYE” or the “Company”) for an

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 03.06.2019

United Bankers Corporation NOTIFICATION 03.06.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 03.06.2019 Date 03.06.2019Exchange transaction BuyShare class UNIAVAmount 94Average price/share 8.1500 EURHighest price/share 8.1500 EURLowest price/share 8.1500 EURTotal price 766.10 EUR The shares held by United Bankers Corporation on 03.06.2019: UNIAV 21,143 On behalf of United Bankers Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

Getinge informs about a medical device recall for Custom Tubing kits for Heart Lung Machine

Getinge is informing about a medical device recall for the custom tubing kits for Heart Lung Machines. To date, there are no known adverse events associated with illness or injuries for the products. Getinge has reported to relevant authorities according to applicable regulations and the cost for the field correction and recall is not material.The Heart Lung Machine (HLM) Tubing Set is part of an extracorporeal system and is used exclusively in combination with other devices of that system, e.g. blood pumps, oxygenators etc. The HLM Tubing Sets are designed to be used for circulation of

APPOINTMENTS IN GLASTON GROUP’S REGIONAL ORGANIZATION

Glaston Corporation  Press Release         3 June 2019Glaston Group has made appointments to the regional organizations as of 31 May 2019. The new regions and the new Heads of the regions will be responsible for the Sales and Service of both Glaston and Bystronic glass products in their respective territories. Glaston Group consists of three Sales Regions: Europe, Middle East, Africa (EMEA), Asia Pacific (APAC) and Americas. Senior Vice President (SVP) Pekka Hytti has been appointed Head of EMEA. He moves to the position from the position as Head of Glaston’s sales and service in EMEA.

#19-927 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#19-926 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Basware Appoints Blair Tolbard General Manager for North America

Fort Mill, SC — June 3, 2019 -- Basware (BAS1V) , the global leader in networked source-to-pay solutions, e-invoicing and innovative financing services, is pleased to welcome Blair Tolbard as its General Manager and Vice President of Sales for North America, effective June 3, 2019. Tolbard, a veteran of the enterprise software industry, recently served as Group Vice President of Sales for JAGGAER. “Our team in North America is brimming with tremendous talent; Blair, with his results-driven nature and track record of building and nurturing highly effective

Sleeping with Punkt.

The AC 01 alarm clock. The only tech you need beside your pillow.Making the switch to a balanced relationship with technology?  Step 1: ban phones from the bedroom, and get an alarm clock. Until June 30th, every e‑shop purchase of an AC 01 (red, white or silver) qualifies for a free copy of Matthew Walker's book 'How We Sleep'. Just add the code “WhyWeSleep” when prompted. Click here  to buy. If we didn’t really know how vital sleep is for our good health and wellbeing before the digital revolution, we certainly do now. The

Total Voting Rights

3 June 2019 15:00 BST  Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2019 the issued share capital of AstraZeneca PLC with voting rights is 1,311,776,898 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,311,776,898. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will

Gapwaves mm-Wave antenna featured with NXP 5G beamforming ICs

As part of a collaboration between Gapwaves and NXP, a jointly developed 5G-application will be exhibited by NXP at International Microwave Symposium in Boston in June. The application, featuring a 28GHz active antenna from Gapwaves, will be exhibited in conjunction with NXP’s 5G analog beamforming ICs. The 5G solution presented is a proof of concept, small cell, hotspot antenna application suitable for e.g. high-density and indoor areas.By a way to develop high-performance 5G mm-Wave solutions, Gapwaves has collaborated with NXP, one of the world’s leading suppliers of semiconductors. As

Nustay enters partnership agreement with Methabook

Today, Nustay A/S (“Nustay”) announces that the company has entered into a distribution agreement with Methabook (“Methabook”) regarding inclusion of their full inventory of approx. 189,000 hotels and other similar properties on Nustay’s hotel booking platform. Methabook is a Dubai-based B2B supplier. The agreement was signed in June 3rd, 2019 and will be ongoing until further notice.CEO Mathias Lundoe Nielsen comments: “I am happy to announce this new agreement with Methabook. They are a major player on the B2B hotel supplier market in the Middle East with a world-wide portfolio of

Nustay confirms Expedia partnership agreement terminated

Today, Nustay A/S (“Nustay”) confirms that EAN.com, LP (“Expedia”) via Accomnews.com.au have told that they have terminated the partnership agreement with Nustay, which Nustay hereby confirms. The termination will not have influence on Nustay’s cash EBITDA. Expedia is not an attractive hotel inventory source for Nustay.CEO Mathias Lundoe Nielsen comments: ”Nustay’s mission is to offer the lowest hotel prices on the market in the interest of the consumers and we look forward to continue to do so”. For further information about Nustay, please contact:                         Mathias

BerGenBio presents new Phase II clinical data that bemcentinib in combination with low dose chemotherapy improves efficacy and duration of survival in elderly AML patients at ASCO 2019

· Phase II trial evaluating bemcentinib in combination with low-intensity chemotherapy in elderly AML patients unfit for intensive therapy shows promising efficacy · 6 out of 13 (46%) patients receiving LDAC combination achieved an Overall Response Rate (ORR) of 46% · 3 out of 12 evaluable patients receiving decitabine combination achieved an ORR of 25% · ORR significantly higher than previously observed/historical benchmarks in single-agent cytarabineChicago, USA, 03 June 2019 – BerGenBio ASA (OSE:BGBIO) today presents data showing significant efficacy in Phase II clinical trials (

Immunovia announces excellent results across all symptomatic risk groups from IMMray™ PanCan-d optimization work

IMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launchIMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launch LUND, SWEDEN - Immunovia AB (publ) (“Immunovia”) today announced that the optimization work for the commercial version of IMMray™ PanCan-d, designed for early detection of pancreatic cancer (PDAC), has been successful and significantly improved the performance of the test. The test now shows accuracies higher than 90% and even up to 98% in differentiating PDAC of stage I through IV versus

Neste: Finland to join Nordic forefront in reducing emissions in aviation

Neste Corporation, Press Release, 3 June 2019 at 4 pm. (EET) Finland’s incoming government has today introduced its Government Programme which includes ambitious climate targets and a goal for carbon neutral Finland in 2035. As part of reducing transport-related emissions, the share of biofuels in aviation is targeted at 30% through a blending obligation. “This is a significant goal, enabling Finland to join the forerunners in reducing emissions in aviation. Air traffic is predicted to double during the next 15 years. The aviation industry has committed to carbon neutral growth

Fellow Finance's platform facilitated 18,2 million euros of loans in May

FELLOW FINANCE PLC PRESS RELEASE 3.6.2019 at 4:00 pmFellow Finance's platform facilitated 18,2 million euros of loans in May Fellow Finance investors funded business and peer-to-peer loans worth around 18,2M€ in May. Cumulative loan volume grew over 454 million euros and the total number of investors grew to 12 655. Check the real-time peer-to-peer lending statistics on our website: www.fellowfinance.com/for-investor/statistics. Fellow Finance Plc launched its operations in 2014 and it is an internationally active and growth-oriented FinTech group that provides crowdfunding services

New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting

Stockholm - 3 June 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers, announced today new data presented at the the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting from its Phase 1/2 O-12-M1 clinical study of lead candidate melflufen. The data demonstrate that melflufen may offer positive disease stabilization and favorable time to next treatment (TTNT) outcomes in heavily-pretreated patients with relapsed/refractory multiple myeloma (RRMM).Overall

There are no items matching the current filter
There are no more items matching the current filter
Back to top